Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

GreenBox POS, LLC (GRBX) Focuses on Increasing Transaction Volume Across its Blockchain-based Payment Solutions Platform

GRBX expects to ship enough new integrated hardware and software units to bring $750,000 in monthly net income by year-end GreenBox has a goal of processing $1 billion of transactional volume in FY2019 The company recently acquired Sky Mids Technologies, boosting its volume capacity GRBX is well positioned in multiple rapidly growing sectors, including payments […]

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) Closes Private Placement Financing, Engages Communications and Marketing Services

Marifil Mines recently closed a private placement financing Marifil has hired UnityWest Capital Markets to provide marketing services Canada One Communication has been engaged to provide Marifil’s investor relations Mining exploration company Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) has announced closings of multiple private placement financings, as well as the engagement of firms to […]

Medical Cannabis Payment Solutions (REFG): A Cannabis Industry Pioneer

Medical Cannabis Payment Solutions serves the legal cannabis industry with an end-to-end payment processing solution The company serves medical and recreational-related businesses and dispensaries Its payment solution card is unique for purchasing cannabis-related products from state-sanctioned merchants Medical Cannabis Payment Solutions (OTC: REFG) is a first-tier merchant processing cannabis industry innovator. The company serves the […]

CytoDyn Inc. (CYDY) to Complete Development of Prostate Cancer Prognostic Test Following Close of ProstaGene Acquisition

PCaTest has already proven a superior predictive ability in comparison with other genetic prognostic tests Cytodyn in the process of acquiring PCaTest developer ProstaGene and will launch a clinical study once the transaction is complete Prostate cancer is the second-most common type of cancer among American men, with almost 165,000 new cases expected this year […]

CytoDyn Inc. (CYDY) Finding Success in Trials of PRO 140 for Treatment of HIV/AIDS; Plans to Expand Clinical Investigations to Cancer

Lead product candidate, PRO 140, is a viral-entry inhibitor that works by blocking the entry of HIV/AIDS to healthy cells by masking CCR5 receptor Completion of Biological License Application (BLA) for potential approval in combination HIV therapy expected in Q1 2019 CytoDyn received approval to increase dosing of PRO 140 in its phase 3 adaptive […]

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) Encounters Lithium Brines in Additional Drill Holes, Confirming Geophysical Profile of Ollague Project

Drilling shows additional lithium-bearing brines carrying highly conductive zones, suggesting that lithium grades increase with depth Brines tested lithium grades starting at 150 mg/l, increasing to 270 mg/l when drill holes reached 250-meter contracted depth Results of recent drilling reinforce company’s decision to test deeper limits of aquifer Lithium Chile holds one of the largest […]

Cannabis Strategic Ventures, Inc. (NUGS) Welcomes PureOrganix Shelf Presence as Sign of Life in Growing Industry

Americans spending a growing amount of capital on cannabis concentrates, with forecasts for $2.9 billion in sales this year Cannabis Strategic Ventures recently announced the introduction of high-quality concentrate line PureOrganix in California dispensaries PureOrganix presence expected to gain national, international footing amid advancing tide of cannabis legalization Cannabis industry incubator Cannabis Strategic Ventures, Inc. […]

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advances Breast Cancer Therapy Trials to Patient Dosing Stage

Breast cancer is the leading cancer diagnosed in women and the second-most common cancer overall BriaCell Therapeutics has begun patient dosing in clinical trials that combine its trademarked Bria-IMT technology with celebrated cancer-fighting antibodies The clinical trials are working on a therapy that will help the body’s own immune system fight cancerous cells The battle […]

 

From Our Blog

Numa Numa Resources Inc. Positioned Amid Rising Geopolitical Interest

December 2, 2025

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Numa Numa Resources is operating in one of the most geopolitically significant mining regions in the world, and recent diplomatic developments suggest that Bougainville’s role in global resource security is drawing heightened international attention. As the United States engages more directly with […]

Rotate your device 90° to view site.